2019 Chinese Hypertension League guidelines on home blood pressure monitoring

Wang, Ji‐Guang; Bu, Peili; Chen, Luyuan; Chen, Xin; Chen, Yuanyuan; Cheng, Wenli; Chu, Shaoli; Cui, Zhaoqiang; Dai, Qiuyan; Feng, Yingqing; Jiang, Xiongjing; Jiang, Yinong; Li, Weihua; Li, Yan; Li, Yong; Lin, Jinxiu; Liu, Jing; Mu, Jianjun; Yingxin, Peng; Song, Lei; Sun, Ning; Wang, Yan; Yang, Xi; Xie, Liangdi; Xue, Hao; Yu, Jing; Yu, Wei; Zhang, Yuqing; Zhu, Zhiming

doi:10.1111/jch.13779

Cited by 31 publications

(27 citation statements)

References 20 publications

(39 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The HOPE Asia Network has published a number of papers on important Asia‐specific topics in hypertension . This Asia‐specific issue of the Journal of Clinical Hypertension provides an important resource including original research and review articles on the management of hypertension from a variety of Asian viewpoints, including topics such as central BP, environmental factors, comorbidities such as diabetes, atrial fibrillation, heart failure, and dementia, recent Asian guidelines and so forth . This issue also includes reports from twelve countries/regions in Asia to help define and highlight the current status of hypertension, its management, and their initiatives.…”

Section: Resultsmentioning

confidence: 99%

The HOPE Asia Network activity for “zero” cardiovascular events in Asia: Overview 2020

Kario

2020

J of Clinical Hypertension

View full text Add to dashboard Cite

The impact of hypertension-related cardiovascular disease and target organ damage, and therefore the benefits of blood pressure (BP) control, is greater in Asian than in Western countries. Asia-specific features of hypertension and its effective management are important and active areas of research. The Hypertension Cardiovascular Outcome Prevention and Evidence in Asia (HOPE Asia) Network was formed in 2016and is now a member of the World Hypertension League. The main goal of the HOPE Asia Network is to improve the management of hypertension and organ protection toward achieving "zero" cardiovascular events in Asia. Considerable work has already been done on the journey to achieving this goal. We have shown that BP control status in Asia differs between countries, and even between regions within the same country. Several expert panel consensus recommendations and clinical guidance papers are available to support the use of home and ambulatory BP monitoring in the region. In addition, the AsiaBP@Home study prospectively investigated home BP control status across 15 specialist centers using the same validated device and measurement schedule. We have also proposed the concept of systemic hemodynamic atherothrombotic syndrome (SHATS), a vicious cycle of BP variability and vascular disease on cardiovascular events and organ damage, and suggested a SHATS score for risk stratification for clinical practice. This special issue of the journal collates Asia-specific resources and data, contributing to advances in hypertension management and cardiovascular disease prevention in the region.

show abstract

Section: Resultsmentioning

confidence: 99%

The HOPE Asia Network activity for “zero” cardiovascular events in Asia: Overview 2020

Kario

2020

J of Clinical Hypertension

View full text Add to dashboard Cite

show abstract

“…The target independent variable was the different methods of BP management, with or without HBPT. The dependent variable was BP control (dichotomous variable: 1 = BP control was defined as home systolic blood pressure (SBP) < 135 mm Hg and home diastolic blood pressure (DBP) < 85 mm Hg following 2019 Chinese Hypertension League guidelines on home blood pressure monitoring 22 ; 0 = uncontrolled BP was defined as home SBP ≥135 mm Hg or home DBP ≥85 mm Hg).…”

Section: Participants and Methodsmentioning

confidence: 99%

Home blood pressure telemonitoring for improving blood pressure control in middle‐aged and elderly patients with hypertension

Yue

Yang

Wang

et al. 2021

J of Clinical Hypertension

View full text Add to dashboard Cite

The blood pressure (BP) control rate among treated hypertensives in China remains low at 37.5%. The relationship between home blood pressure telemonitoring (HBPT) and BP control is controversial. The authors aimed to investigate the relationship between HBPT and BP control in middle‐aged and elderly hypertensives. In total, 252 hypertension patients aged between 60 and 79 years were enrolled. The patients were given either HBPT through interactive platforms between physicians and patients (telemonitoring group, n = 126) or conventional management (routine management group, n = 126). All patients were followed‐up for 15 months. BP control was defined as home systolic blood pressure < 135 mm Hg and home diastolic blood pressure < 85 mm Hg. At baseline, there were no significant differences in the baseline BP control rate (p = .083). However, after 15 months, the BP control rate improved in both groups, and the telemonitoring group (71.3%) had a significantly higher BP control than the routine management group (49.8%) (p < .001). The change of BP control rate from baseline in the routine management group increased by 26.1%, and that of the telemonitoring group increased by 35.4%. The results of the fully adjusted binary logistic regression showed that HBPT was positively associated with BP control after adjusting for confounders (OR = 4.15, 95% CI 2.05–8.39). Similar results were observed after 3, 9, and 12 months. The association of HBPT with BP control was similar in subgroups. In conclusions, HBPT is recommended for BP control in middle‐aged and elderly hypertensives in the community setting.

show abstract

“… 1 In addition to being validated, the HBPM device should use an upper-arm cuff oscillometric method (with an appropriately sized cuff) and be able to automatically store all readings; telehealth-equipped devices that can transmit readings to healthcare providers are preferable. 1 , 5 , 16 , 17 The patient should have an empty bladder, and rest quietly in a seated position with the back supported and both feet on the floor for 2–5 minutes before taking home BP measurements. The cuff of the device should be placed directly above the elbow and pulled taut, with the arm supported on a flat surface.…”

Section: Home Bp Measurement: Schedule Thresholds and Approachesmentioning

confidence: 99%

Home Blood Pressure Monitoring: Current Status and New Developments

Kario

2021

American Journal of Hypertension

View full text Add to dashboard Cite

Home blood pressure monitoring (HBPM) is a reliable, convenient and less costly alternative to ambulatory blood pressure monitoring (ABPM) for the diagnosis and management of hypertension. Recognition and use of HBPM has dramatically increased over the last 20 years and current guidelines make strong recommendations for the use of both HBPM and ABPM in patients with hypertension. The accuracy and reliability of home BP measurements requires use of a validated device and standardized procedures, and good patient information and training. Key HBPM parameters include morning BP, evening BP and the morning-evening difference. In addition, newer semi-automatic HBPM devices can also measure nighttime BP at fixed intervals during sleep. Advances in technology mean that HBPM devices could provide additional relevant data (e.g. environmental conditions) or determine BP in response to a specific trigger (e.g. hypoxia, increased heart rate). The value of HBPM is highlighted by a growing body of evidence showing that home BP is an important predictor of target organ damage, and cardiovascular disease- and stroke-related morbidity and mortality, and provides better prognostic information than office BP. In addition, use of HBPM to monitor antihypertensive therapy can help to optimize reductions in BP, improve BP control, and reduce target organ damage and cardiovascular risk. Overall, HBPM should play a central role in the management of patients with hypertension, with the goal of identifying increased risk and predicting the onset of cardiovascular disease events, allowing proactive interventions to reduce risk and eliminate adverse outcomes.

show abstract

2019 Chinese Hypertension League guidelines on home blood pressure monitoring

Cited by 31 publications

References 20 publications

The HOPE Asia Network activity for “zero” cardiovascular events in Asia: Overview 2020

The HOPE Asia Network activity for “zero” cardiovascular events in Asia: Overview 2020

Home blood pressure telemonitoring for improving blood pressure control in middle‐aged and elderly patients with hypertension

Home Blood Pressure Monitoring: Current Status and New Developments

Contact Info

Product

Resources

About